LEADER 03664nam 2200649 a 450 001 996206965003316 005 20230417204803.0 010 $a1-280-78387-7 010 $a9786613694263 010 $a0-470-72054-9 010 $a0-470-71822-6 035 $a(CKB)1000000000688123 035 $a(EBL)703893 035 $a(OCoLC)797918447 035 $a(SSID)ssj0000715462 035 $a(PQKBManifestationID)11404027 035 $a(PQKBTitleCode)TC0000715462 035 $a(PQKBWorkID)10704436 035 $a(PQKB)10043916 035 $a(MiAaPQ)EBC703893 035 $a(Au-PeEL)EBL703893 035 $a(CaPaEBR)ebr10575533 035 $a(CaONFJC)MIL369426 035 $a(EXLCZ)991000000000688123 100 $a20791016d1980 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBlood cells and vessel walls $efunctional interactions : in honour of Dr. J. L. Gowans, FRS 210 1$aAmsterdam ;$aNew York :$cExcerpta Medica,$d1980. 215 $a1 online resource (372 pages) $cillustrations 225 1 $aCiba Foundation symposium ;$v71 (new ser.) 300 $aDescription based upon print version of record. 311 0 $a0-470-66382-0 311 0 $a0-444-90112-4 320 $aIncludes bibliographical references and indexes. 327 $aBlood Cells and Vessel Walls: functional interactions; Contents; Chairman's introduction; The haemopoietic microenvironment of bone marrow: an ultrastructural study of the interactions of blood cells, stroma and blood vessels; Discussion; Immunoelectron-microscopic characterization of lymphoid microenvironments in the lymph node and thymus; Discussion; Structural and functional differentiation of microvascular endothelium; Discussion; Haemodynamic and biochemical interactions in intravascular platelet aggregation; Discussion; Prostacyclin; Discussion; General Discussion I 327 $aEndothelial products; Ia antigens; Permeability of small vessels to cells; The function and pathways of lymphocyte recirculation; Discussion; Reassortment of cell populations within the lymphoid apparatus of the sheep; Discussion; Lymphocyte recirculation in the sheep fetus; Discussion; Lymphocyte traffic through lymph nodes during cell shutdown; Discussion; Effect of skin painting with oxazolone on the local extravasation of mononuclear cells in sheep; Discussion; Metabolic studies of high-walled endothelium of postcapillary venules in rat lymph nodes; Discussion; General Discussion II 327 $aAdherence of lymphocytes to the high endothelium of lymph nodes in vitro; Discussion; Cellular, genetic and evolutionary aspects of lymphocyte interactions with high-endothelial venules; Discussion; Macrophages and the differential migration of lymphocytes; Discussion; Polymorphonuclear leucocyte chemotaxis: detection of the gradient and development of cell polarity; Discussion; Dynamic theory of leucocyte adhesion; Discussion; Final General Discussion 'Receptors' and adhesion; Summing up; Epilogue; Index to contributors; Subject index 410 0$aCiba Foundation symposium ;$vnew ser. 71. 606 $aBlood cells$vCongresses 606 $aVascular endothelium$vCongresses 606 $aBlood-vessels$vCongresses 615 0$aBlood cells 615 0$aVascular endothelium 615 0$aBlood-vessels 676 $a591.1/1 701 $aGowans$b J. L$0903406 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996206965003316 996 $aBlood cells and vessel walls$92019572 997 $aUNISA LEADER 01943nam 2200385 450 001 9910135039503321 005 20230808205336.0 010 $a1-59193-608-X 035 $a(CKB)4330000000012154 035 $a(MiAaPQ)EBC4555281 035 $a(EXLCZ)994330000000012154 100 $a20161013d2016 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aMinnesota day trips by theme /$fby Mary M. Bauer 205 $aThird edition. 210 1$aCambridge, Minnesota :$cAdventure Publications,$d2016. 215 $a1 online resource (161 pages) $ccolor illustrations 225 1 $aDay trips series 300 $aIncludes index. 311 $a1-59193-550-4 330 $a"Discover hundreds of unique attractions around the Land of 10,000 Lakes. Take a simple day trip, or string together a longer vacation of activities that catch your interest. No more information overload! Useful for singles, couples and families -- visitors and residents alike -- this guide encompasses a wide range of interests. Features you'll appreciate: sections divided by theme for easy reference -- decide what to do, then figure out where to do it; designations based on such themes as waterfalls, garden tours, small town antiquing, family days and extreme adventures; websites listed for the sites in this guide; tips for other things to do while you're in the area; [and a] handy size that's perfect for traveling. You'll find: museums, state parks and scenic byways; the best winter activities in the state; [and] highlights of Duluth and Rochester." -- Page [4] of cover. 410 0$aDay trips series. 607 $aMinnesota 700 $aBauer$b Mary M.$01245760 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910135039503321 996 $aMinnesota day trips by theme$92889084 997 $aUNINA LEADER 04782nam 2200637Ia 450 001 9910778706803321 005 20230331015409.0 010 $a1-280-21418-X 010 $a9786610214181 010 $a0-309-53588-3 010 $a0-585-00192-8 035 $a(CKB)111004366658478 035 $a(EBL)3376803 035 $a(SSID)ssj0000106760 035 $a(PQKBManifestationID)11133880 035 $a(PQKBTitleCode)TC0000106760 035 $a(PQKBWorkID)10131956 035 $a(PQKB)10108677 035 $a(Au-PeEL)EBL3376803 035 $a(CaPaEBR)ebr10060370 035 $a(OCoLC)923266189 035 $a(MiAaPQ)EBC3376803 035 $a(EXLCZ)99111004366658478 100 $a20040923d1989 my 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAssessment of diagnostic technology in health care$b[electronic resource] $erationale, methods, problems, and directions /$fHarold Sox ... [et al.] 210 $aWashington, D.C. $cNational Academy Press$d1989 215 $a1 online resource (152 p.) 225 1 $aMonograph of the Council on Health Care Technology 300 $aDescription based upon print version of record. 311 $a0-309-04099-X 320 $aIncludes bibliographical references. 327 $a""Assessment of Diagnostic Technology in Health Care""; ""Copyright""; ""Preface""; ""Contents""; ""Introduction""; ""REFERENCES""; ""1 Rationale for Assessment of Diagnostic Technology""; ""THE PATIENT'S PERSPECTIVE""; ""Safety""; ""Efficacy""; ""Economic Issues""; ""The Benefits of High-Quality Studies""; ""The Risks of Poor or Absent Assessment Data""; ""Summary: The Patient's Perspective""; ""SOCIETY'S PERSPECTIVE""; ""Safety and Efficacy""; ""Economic Issues""; ""Summary: Society's Perspective""; ""THE PHYSICIAN'S PERSPECTIVE""; ""Safety and Efficacy""; ""Economic Issues"" 327 $a""Summary: The Physician's Perspective""""SUMMARY""; ""REFERENCES""; ""2 The Use of Diagnostic Tests: A Probabilistic Approach""; ""FIRST PRINCIPLES""; ""INTERPRETING TEST RESULTS: THE POSTTEST PROBABILITY""; ""Important Definitions""; ""The Assumptions of Bayes' Theorem""; ""THE PRETEST PROBABILITY OF DISEASE""; ""MEASURING THE PERFORMANCE CHARACTERISTICS OF DIAGNOSTIC TESTS""; ""Designing Studies of Test Performance""; ""EXPECTED-VALUE DECISIONMAKING""; ""Setting Up the Decision Tree""; ""Weighing the Outcomes for Quality of Life"" 327 $a""Calculating the Expected Value of the Treatment Options""""THE CHOICE AMONG DOING NOTHING, TESTING, OR STARTING TREATMENT""; ""SUMMARY""; ""Glossary Of Terms""; ""REFERENCES""; ""3 Assessment: Problems and Proposed Solutions""; ""MEASURES OF CLINICAL EFFICACY""; ""Technical Capability""; ""Sensitivity and Specificity""; ""Diagnostic Impact""; ""Therapeutic Impact""; ""Impact on Clinical Outcomes""; ""THE SYSTEM OF TECHNOLOGY ASSESSMENT IN THE UNITED STATES""; ""The Pyramid""; ""PROBLEMS WITH THE CURRENT SYSTEM""; ""RANDOMIZED TRIALS OF DIAGNOSTIC TESTS"" 327 $a""Limitations of Randomized Trials""""Trial Design""; """"OFF THE GOLD STANDARD""""; """"ON THE GOLD STANDARD""""; ""A PROPOSAL FOR MODEL-DRIVEN TECHNOLOGY ASSESSMENT""; ""A Technology Should Be Compared with a Competing Technology""; ""STUDIES SHOULD BE PLANNED BEFORE ENROLLING THE FIRST PATIENT""; ""ALL THE DATA THAT ARE NEEDED FOR CLINICAL DECISION MAKING SHOULD BE COLLECTED""; ""BIAS IN PATIENT SELECTION SHOULD BE AVOIDED""; ""PATIENTS SHOULD BE OBSERVED FOR ADVERSE EFFECTS OF THE INDEX TEST""; ""INTERPRETATION OF DATA SHOULD BE FREE OF BIAS"" 327 $a""INTEROBSERVER DISAGREEMENT SHOULD BE MEASURED""""THERE SHOULD BE ENOUGH PATIENTS TO REPORT THE RESULTS IN CLINICALLY USEFUL SUBGROUPS OF PATIENTS""; ""SUMMARY""; ""REFERENCES""; ""4 Primary Assessment of Diagnostic Tests: Barriers to Implementation""; ""PLANNING AND PROTOCOL DEVELOPMENT""; ""Choosing a Clinical Condition""; ""Patient Population""; ""Endpoints and Study Design""; ""ACCURACY""; ""OUTCOME""; ""COMBINED STUDIES: ACCURACY AND OUTCOME""; ""SHORT-TERM OUTCOMES: A SYNTHETIC APPROACH""; ""Economic Analysis""; ""Efficacy Versus Effectiveness""; ""Comparative Assessment"" 327 $a""Sample Size"" 410 0$aMonograph of the Council on Health Care Technology. 606 $aDiagnosis$xMethodology$xEvaluation 606 $aMedical technology$xEvaluation 615 0$aDiagnosis$xMethodology$xEvaluation. 615 0$aMedical technology$xEvaluation. 676 $a616.075 701 $aSox$b Harold C$0896480 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910778706803321 996 $aAssessment of diagnostic technology in health care$93845374 997 $aUNINA